China Vaccine Industry Report, 2009-2010
  • Sep/2010
  • Hard Copy
  • USD $1,900
  • Pages:111
  • Single User License
    (PDF Unprintable)       
  • USD $2,000
  • Code: ZYM009
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,000
  • Hard Copy + Single User License
  • USD $2,100
Being one of the world's largest vaccine producers, China not only has many vaccine companies, various vaccine categories and large quantity, but also the human and animal vaccine enterprises are in general separated. At the end of 2009, there were around 38 human vaccine manufacturers and 54 animal vaccine producers that had passed CMP certification in China. With the development of national economy and the people’s growing awareness of precautionary measures, Chinese vaccine market scale had increased continuously, with a CAGR of 21.5% during 2007-2009. In addition, the vaccine market size of China reached RMB15.2 billion in 2009, of which around RMB9 billion of human vaccine and RMB6.2 billion or so of animal vaccine were included.

Human Vaccine and Animal Vaccine Market Scale of China, 2007-2009 (Unit: RMB bn)
Source: SFDA, ResearchInChina

The vaccine industry is featured by high investment, high risk, long cycle and high profit. In spite of somewhat drop in profit in recent years due to increasingly intensive market competition, the overall profitability of the vaccine industry is still kept at a relatively high level thanks to the lower risk of disorderly competition as well as the restriction of barriers like policy, technology and capital. In 2009, the gross margin of animal vaccine industry was over 60%, and that of human vaccine industry was higher, above 70%.

Gross Margins of Major Human Vaccine Companies in China, 2007-2009
Source: Annals, ResearchInChina
In fact, the compulsory and free EPI vaccines are dominant in inoculation vaccines in China on account of relatively low economic level and comparatively lower awareness of epidemic precaution. Taking human vaccine market for example, the release of EPI human vaccines reached 648.4261 million person doses in 2009, accounting for 80.4% of the total; while the extra EPI vaccine was only 158.512 million person doses, with a share of 19.6%. Yet, the sum of EPI vaccine only occupied 38.9% of the total being restricted by governmental procurement price, while the extra EPI vaccine covered 61.1%.

Focusing upon the overall vaccine market of China, the report also delves into the development status quo, market scale, market demand & supply, competition pattern, import & export, development prospect and relevant companies of human vaccine and animal vaccine market segments.
1. Overview of Vaccine Industry
1.1 Definition & Classification
1.2 Industry Chain

2. China Vaccine Industry
2.1 Overview
2.2 Operating Environment
2.2.1 International Market
2.2.2 Policy Environment
2.2.3 Biopharmaceutical Market in China

3. China Human Vaccine Market
3.1 Status Quo
3.2 Market Size & Gross Profit
3.3 Supply & Demand
3.4 Competition Pattern
3.5 Sales Channel
3.6 Dynamics

4. Human Vaccine Market Segments in China
4.1 Hepatitis B Vaccine
4.1.1 Supply & Demand
4.1.2 Competition Pattern
4.2 Meningococcal Vaccines
4.2.1 Supply & Demand
4.2.2 Competition Pattern
4.2.3 Market Forecast
4.3 Hepatitis A Vaccine
4.3.1 Supply & Demand
4.3.2 Competition Pattern
4.3.3 Market Forecast
4.4 Influenza Vaccine
4.4.1 Supply & Demand
4.4.2 Competition Pattern
4.5 Hib Vaccine
4.5.1 Supply & Demand
4.5.2 Market Forecast
4.6 Rabies Vaccine
4.6.1 Supply & Demand
4.6.2 Dynamics
4.6.3 Market Forecast
4.7 Varicella Vaccine
4.7.1 Supply & Demand
4.7.2 Competition Pattern

5. China Animal Vaccine Market
5.1 Status Quo
5.2 Market Scale
5.3 Supply & Demand
5.4 Market Competition
5.5 Market Segments
5.5.1 Swine Vaccines
5.5.2 Poultry Vaccines
5.5.3 Cattle & Sheep Vaccines
5.5.4 Pet Vaccines
5.6 Development Factors
5.7 Market Forecast

6. China’s Import and Export of Vaccines in 2009-2010
6.1 Human Vaccines
6.1.1 Import
6.1.2 Export
6.2 Animal Vaccines
6.2.1 Import
6.2.2 Export

7. Major Vaccine Manufacturers in China
7.1 China National Biotec Group
7.1.1 Beijing Tiantan Biological Products Co., Ltd
7.1.2 Shanghai Institute of Biological Products
7.2 Hualan Biological Engineering Inc.
7.2.1 Operation
7.2.2 Operation of Vaccine Business
7.2.3 Prospect of Vaccine Business
7.3 Liaoning Chengda Biotechnology Co., Ltd
7.3.1 Operation
7.3.2 Operation of Vaccine Business
7.3.3 Prospect of Vaccine Business
7.4 Chongqing Zhifei Biological Products Co., Ltd
7.4.1 Profile
7.4.2 Operation
7.4.3 Development Plan
7.5 Walvax Biotechnology Co., Ltd
7.5.1 Profile
7.5.2 Operation
7.5.3 Vaccine Projects
7.6 Sinovac Biotech Ltd.
7.6.1 Profile
7.6.2 Development
7.7 Changchun Changsheng Life Sciences Limited
7.8 Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd
7.9 Shenzhen Kangtai Biological Products Co. Ltd
7.10 Dalian Hissen Bio-Pharm Co., Ltd
7.11 Shenzhen Neptunus Bioengineering Co., Ltd
7.11.1 Operation
7.11.2 Vaccine Business & Development
7.12 Star Lake Bioscience
7.12.1 Operation
7.12.2 Vaccine Business & Development
7.13 China Animal Husbandry Industry Co., Ltd (CAHIC)
7.13.1 Profile
7.13.2 Operation
7.13.3 Status Quo of Animal Vaccine Business
7.13.4 Development Outlook of Animal Vaccine Business
7.14 Inner Mongolia Jinyu Group Co., Ltd
7.14.1 Profile
7.14.2 Operation
7.14.3 Status Quo of Animal Vaccine Business
7.14.4 Development Outlook of Animal Vaccine Business
7.15 Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd
7.15.1 Operation
7.15.2 Animal Vaccine Business
Classification of Vaccines
Vaccine Industry Chain
Market Scale: Human Vaccine vs Animal Vaccine, 2007-2009
EPI Vaccine Varieties in China, 2010
Global Sales Value and Growth: Human Vaccine vs Animal Vaccine, 2007-2009
Sales Value of the Global Top 5 Vaccine Manufacturers, 2007-2009
R &D of New Vaccines Worldwide, 2009-2010
Main Mergers & Acquisitions in the Vaccine Industry Worldwide, 2005-2010
Policies in Vaccine Industry
Sales Value and Growth Rate of Biological & Biochemical Product Industry in China, 2008-May 2010
Major Human Vaccine Varieties and Producers in China
The Release and Percentage (by Volume) of EPI and Extra EPI Vaccines in China, 2007-2009
The Release and Percentage (by Sum) of EPI and Extra EPI Vaccines in China, 2007-2009
China’s Human Vaccine Market Scale, 2006-2009
Gross Margin of Major Human Vaccine Manufacturers in China, 2007-2009
Market Supply and Demand of Some EPI Vaccines, 2009
China’s EPI Human Vaccine Market Shares by Release, 2007-2009
China’s Non-EPI Human Vaccine Market Shares by Release, 2007-2009
Vaccine Distribution Channel in China
R&D of New Human Vaccines in China as of H1 2010
Release of “Recombinant Hepatitis B Vaccine” Manufacturers in China, H1 2009 vs. H1 2010
Manufactures that Obtained Certificate of “Recombinant Hepatitis B Vaccine”, by Jun. 2010
Release & Percentages of Hepatitis B Vaccine Manufacturers in China, Jan.-Aug. 2010
Sales Volume and Growth Rate of MPSV4 AC in China, 2006-2009
Sales Revenue and Growth Rate of MPSV4 AC in China, 2006-2009
Sales Volume and Growth Rate of MCV4 AC in China, 2006-2009
Sales Revenue and Growth Rate of MCV4 AC in China, 2006-2009
Sales Volume and Growth Rate of MPSV4 ACYW135 in China, 2008-2009
Sales Revenue and Growth Rate of MPSV4 ACYW135 in China, 2008-2009
Market Shares of MPSV4 ACYW135 Manufacturers in China, Jan.-Aug. 2010 (by Release)
Sales Volume Forecast of MPSV4 AC, Meningococcal Polysaccharide Conjugate Vaccine AC and MPSV4 ACYW135 in China, 2010-2013
Sales Revenue Forecast of MPSV4 AC, Meningococcal Polysaccharide Conjugate Vaccine AC and MPSV4 ACYW135 in China, 2010-2013
Capacity and Output of Hepatitis A Vaccine in China, 2006-2009
Sales Volume and Growth Rate of Hepatitis A Vaccine in China, 2006-2009
Sales Revenue and Growth Rate of Hepatitis A Vaccine in China, 2006-2009
Sales Volume Forecast of Hepatitis A Vaccine in China, 2010-2013
Sales Revenue Forecast of Hepatitis A Vaccine in China, 2010-2013
Release Volume of Influenza Vaccine in China, 2009-H1 2010
Market Shares of Split Influenza Virus Vaccine Manufacturers in China, 2009 (by Release)
Shares of Chinese Subunit Influenza Vaccine Market, 2009 (by Release)
Capacity and Output of Hib Vaccine in China, 2006-2009
Sales Volume and Growth Rate of Hib Vaccine in China, 2006-2009
Sales Revenue and Growth Rate of Hib Vaccine in China, 2006-2009
Sales Volume and Growth Rate of Hib Vaccine in China, 2010-2013E
Sales Revenue and Growth Rate of Hib Vaccine in China, 2010-2013E
Sales Volume and Growth Rate of Human Rabies Vaccine in China, 2006-2009
Sales Value and Growth Rate of Human Rabies Vaccine in China, 2006-2009
Selling Price of Human Rabies Vaccine in China, 2006-2009
Capacity and Output of Human Rabies Vaccine in China, 2006-2009
Sales Volume Forecast of Human Rabies Vaccine in China, 2010-2013
Sales Value Forecast of Human Rabies Vaccine in China, 2010-2013
Main Manufacturers of Varicella Vaccine and Their Releases, 2009-Apr.2010
Chinese Varicella Vaccine Market Shares, 2009 (by Release)
China’s Animal Vaccine Market Share by Category, 2009
China’s Animal Vaccine Industry Market Scale & Growth, 2006-2009
Key Animal Vaccine Manufacturers in China
Production of Main Chinese Animal Vaccine Manufacturers
Consumption Structure of Animal Vaccines (by Animal Species) in China, 2009
China’s Animal Vaccination Program, 2010
Market Shares of Main Chinese Animal Vaccine Manufacturers by Sales, 2009
Number of Leading Animal Vaccine Producers in Governmental Procurement, 2009
China’s Swine Vaccine Market Scale, 2008-2009
Performance Comparison of China’s Various Hog Cholera Vaccines
Poultry Vaccine Market Scale in China, 2008-2009
Ratio of China’s Poultry Vaccine by Category, 2009
Cattle & Sheep Vaccine Market Scale, 2008-2009
Foot and Mouth Disease in China, 2009
Pet Vaccine Market Scale in China, 2008-2010
Pet Vaccine Suppliers in China
Stimulus for the Development of China’s Animal Vaccine Industry
China’s Animal Vaccine Market Scale, 2010
China’s Human Vaccine Import and Export Volume and Value, 2009-Jul. 2010
China’s Human Vaccine Import Volume, 2009-Jul. 2010
China’s Human Vaccine Import Value, 2009-Jul. 2010
China’s Human Vaccine Import Volume and Value by Country, Jan.-Jul. 2010
China’s Human Vaccine Export Volume, 2009-Jul. 2010
China’s Human Vaccine Export Value, 2009-Jul. 2010
China’s Human Vaccine Export Volume and Value by Country, Jan.-Jul. 2010
China’s Animal Vaccine Import and Export Volume and Value, 2009-2010
China’s Animal Vaccine Import Volume, 2009-2010
China’s Animal Vaccine Import Value, 2009-2010
China’s Animal Vaccine Import Volume and Value by Country, Jan.-Jul. 2010
China’s Animal Vaccine Export Volume, 2009-2010
China’s Animal Vaccine Export Value, 2009-2010
China’s Animal Vaccine Export Volume and Value by Country, Jan.-Jul. 2010
Operating Income and Total Profit of Beijing Tiantan Biological Products Co., Ltd, 2006-2010
Operating Income and Growth Rate of Beijing Tiantan Biological Products Co., Ltd, 2007-2010
Measles Vaccine Release and Market Shares of Beijing Tiantan Biological Products Co., Ltd, 2008-2010
Revenue and Profit of Shanghai Institute of Biological Products, 2007-2008
Operating Income and Total Profit of Hualan Biological, 2007-2010
Release and Percentage of Hualan Biological Vaccine Products, 2010
Operating Income and Operating Margin of Hualan Biological Vaccine Products, 2008-2010
Operating Income and Total Profit of Liaoning Chengda, 2007-2010
Vaccine Category and R&D Process of Liaoning Chengda
Operating Income and Operating Margin of Vaccines of Liaoning Chengda, 2008-2010
Sales Volume of Main Vaccines of Liaoning Chengda, 2009-2010
Market Shares of Zhifei Biological Product Segments, 2007-2009
Market Shares of EPI Vaccines of Zhifei Biological, 2007-2009
Revenue and Profit of Zhifei Biological, 2007-2010
Scheduling of the Researching Projects of Zhifei Biological, 2010-2012
Vaccines on the Market and Capacity of Yunnan Walvax
Revenue and Profit of Yunnan Walvax, 2007-2010
Vaccine Projects of Yunnan Walvax
Vaccine Development History of Sinovac Biotech Co., Ltd, 2001-2009
Revenue of Sinovac Biotech Ltd by Product, 2008-2009
Revenue and Profit of Changchuan Changsheng Life Sciences, 2007-2008
Vaccines of Zhejiang Tianyuan Bio-Pharmaceutical
Revenue and Profit of Zhejiang Tianyuan Bio-Pharmaceutical, 2008
SKTB Revenue & Profit, 2007-2008
Operating Income & Total Profit of Hissen Bio-pharm, 2007-2008
Vaccine Projects of Hissen Bio-pharm 
Neptunus Operating Income & Total Profit, 2006-2010
Neptunus Interlong Operating Income & Operating Profit, 2007-2010
Star Lake Bioscience Operating Income & Total Profit, 2007-2010
Operating Income, Total Profit, and Operating Margin of CAHIC, 2007-2010Q1
Sales Volume of CAHIC Animal Vaccines, 2007-2009
Percentages of CAHIC Vaccines, 2009
Gross Profit of CAHIC Animal Vaccines, 2007-2009
Operating Income and Total Profit of Inner Mongolia Jinyu Group, 2007-2010
Operating Income and Operating Margin of Jinyu Animal Vaccines, 2007-2010
Operating Income and Total Profit of Tecon, 2007-2010
Operating Income and Operating Margin of Tecon Animal Vaccines, 2007-2010

China Contract Research Organization (CRO) Industry Report, 2020-2026

The contract research organization (CRO) industry has been galloping amid the global pharmaceutical market steadily in head way, the vibrant financing in the medical and health sector, and the prolife...

China Human Vaccine Industry Report, 2020-2026

In China, the lot release for human vaccines plunged by 17.7% in 2018 when the production record fraud of rabies vaccines for human use, freeze-dried by Changsheng Bio-Technology was exposed. The impa...

China Pharmaceutical Distribution Industry Report, 2019-2026

The Chinese pharmaceutical distribution market has been expanding steadily over the recent years, being valued at RMB2,330.3 billion in 2019 with a year-on-year increase of 8.9%, of which the pharmace...

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号